88 related articles for article (PubMed ID: 21756973)
1. Analysis of expression and structure of the rat GH-secretagogue/ghrelin receptor (Ghsr) gene: roles of epigenetic modifications in transcriptional regulation.
Inoue H; Sakamoto Y; Kangawa N; Kimura C; Ogata T; Fujieda K; Qian ZR; Sano T; Itakura M
Mol Cell Endocrinol; 2011 Oct; 345(1-2):1-15. PubMed ID: 21756973
[TBL] [Abstract][Full Text] [Related]
2. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
4. Identification of promoter region of ghrelin gene in human medullary thyroid carcinoma cell line.
Nakai N; Kaneko M; Nakao N; Fujikawa T; Nakashima K; Ogata M; Tanaka M
Life Sci; 2004 Sep; 75(18):2193-201. PubMed ID: 15325845
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of the 5'-flanking region of the growth hormone secretagogue receptor gene from black seabream Acanthopagrus schlegeli.
Yeung CM; Chan CB; Cheng CH
Mol Cell Endocrinol; 2004 Aug; 223(1-2):5-15. PubMed ID: 15279906
[TBL] [Abstract][Full Text] [Related]
6. Seabream ghrelin: cDNA cloning, genomic organization and promoter studies.
Yeung CM; Chan CB; Woo NY; Cheng CH
J Endocrinol; 2006 May; 189(2):365-79. PubMed ID: 16648303
[TBL] [Abstract][Full Text] [Related]
7. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone stimulates the expression of ghrelin and its receptor in rat hypothalamic 4B cells.
Kageyama K; Akimoto K; Yamagata S; Sugiyama A; Murasawa S; Watanuki Y; Tamasawa N; Suda T
Regul Pept; 2012 Feb; 174(1-3):12-7. PubMed ID: 22120831
[TBL] [Abstract][Full Text] [Related]
9. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M
Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
11. Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines.
Tost J; Hamzaoui H; Busato F; Neyret A; Mourah S; Dupont JM; Bouizar Z
Epigenetics; 2011 Aug; 6(8):1035-46. PubMed ID: 21775817
[TBL] [Abstract][Full Text] [Related]
12. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of lymphocyte-specific inactivation of RAG-2 intragenic promoter of NWC: implications for epigenetic control of RAG locus.
Cebrat M; Cebula A; Laszkiewicz A; Kasztura M; Miazek A; Kisielow P
Mol Immunol; 2008 Apr; 45(8):2297-306. PubMed ID: 18166226
[TBL] [Abstract][Full Text] [Related]
14. Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.
Tshuikina M; Nilsson K; Oberg F
Gene; 2008 Mar; 410(2):259-67. PubMed ID: 18242011
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.
Ribarska T; Ingenwerth M; Goering W; Engers R; Schulz WA
Cancer Genomics Proteomics; 2010; 7(2):51-60. PubMed ID: 20335518
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
17. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
[TBL] [Abstract][Full Text] [Related]
18. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
19. A distinct epigenetic signature at targets of a leukemia protein.
Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
